Clinical Trial Update: A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Very Low Dose-Glucagon in Subjects With Type 1 Diabetes Mellitus [Phase 1]

View source ↗

Summary

A completed Phase 1 trial assessed the safety, tolerability, pharmacokinetics and pharmacodynamic activity of Very Low Dose-Glucagon in subjects with Type 1 Dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Very Low Dose-Glucagon (glucagon)

Snippet

Sponsor: DiObex | Conditions: Type 1 Diabetes | Phase 1 | Status: COMPLETED